Company Glucodiab Srl with Fiscal Code 34116280
recorded a turnover of 2024 of
107.153,
with a net profit of
29.492
and having an average number of employees of
3.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Glucodiab Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
486
5.789
41.543
57.177
46.686
59.247
85.253
90.888
94.345
107.153
Total Income - EUR
486
5.829
42.426
57.177
46.686
59.248
85.253
90.888
94.887
107.728
Total Expenses - EUR
792
882
35.293
60.803
51.159
32.315
46.831
55.239
56.763
75.393
Gross Profit/Loss - EUR
-306
4.947
7.133
-3.626
-4.473
26.933
38.422
35.649
38.124
32.336
Net Profit/Loss - EUR
-321
4.773
6.717
-4.198
-4.940
26.341
37.569
34.740
37.175
29.492
Employees
0
0
5
0
3
0
0
3
3
3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 14.2%, from 94.345 euro in the year 2023, to 107.153 euro in 2024.
The Net Profit decreased by -7.475 euro, from 37.175 euro in 2023, to 29.492 in the last year.
Check the financial reports for the company - Glucodiab Srl
Financial Rating - GLUCODIAB SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Glucodiab Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Glucodiab Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Glucodiab Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
37.292 euro in 2024 which includes Inventories of
80 euro, Receivables of
4.268 euro and cash availability of
32.943 euro.
The company's Equity was valued at
40.979 euro, while total Liabilities amounted to
11.260 euro.
Equity increased by 3.972 euro, from 37.215 euro in 2023, to 40.979 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Glucodiab Srl